Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer ; volume:9 ; number:1 ; day:26 ; month:6 ; year:2014 ; pages:1-9 ; date:12.2014
Radiation oncology ; 9, Heft 1 (26.6.2014), 1-9, 12.2014
- Creator
-
Chen, Leonard N.
- Contributor
-
Suy, Simeng
Wang, Hongkun
Bhagat, Aditi
Woo, Jennifer A.
Moures, Rudy A.
Kim, Joy S.
Yung, Thomas M.
Lei, Siyuan
Collins, Brian T.
Kowalczyk, Keith
Dritschilo, Anatoly
Lynch, John H.
Collins, Sean P.
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-9-148
- URN
-
urn:nbn:de:1111-2016072619651
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Leonard N.
- Suy, Simeng
- Wang, Hongkun
- Bhagat, Aditi
- Woo, Jennifer A.
- Moures, Rudy A.
- Kim, Joy S.
- Yung, Thomas M.
- Lei, Siyuan
- Collins, Brian T.
- Kowalczyk, Keith
- Dritschilo, Anatoly
- Lynch, John H.
- Collins, Sean P.
- SpringerLink (Online service)
Other Objects (12)
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments